COMPANIES COVERED
IlluminaDownload FREE Report Sample
Download Free samplePreimplantation Genetic Diagnosis Market contains market size and forecasts of Preimplantation Genetic Diagnosis (PGD) in Global, including the following market information:
Global Preimplantation Genetic Diagnosis (PGD) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Preimplantation Genetic Diagnosis (PGD) market was valued at 104.6 million in 2021 and is projected to reach US$ 138.6 million by 2028, at a CAGR of 4.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Chromosomal Abnormalities Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Preimplantation Genetic Diagnosis (PGD) include Illumina, Thermo Fisher, Agilent Technologies, PerkinElmer, Coopersurgical, Abbott Laboratories, Natera, Takara Bio and Oxford Gene Technology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Preimplantation Genetic Diagnosis (PGD) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Preimplantation Genetic Diagnosis (PGD) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Preimplantation Genetic Diagnosis (PGD) Market Segment Percentages, by Type, 2021 (%)
Chromosomal Abnormalities
Gender Selection
X-linked Diseases
Aneuploidy
Single Gene Disorders
Others
Global Preimplantation Genetic Diagnosis (PGD) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Preimplantation Genetic Diagnosis (PGD) Market Segment Percentages, by Application, 2021 (%)
Maternity Centers & Fertility Clinics
Hospitals, Diagnostic Labs, and Service Providers
Research Laboratories & Academic Institutes
Global Preimplantation Genetic Diagnosis (PGD) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Preimplantation Genetic Diagnosis (PGD) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Preimplantation Genetic Diagnosis (PGD) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Preimplantation Genetic Diagnosis (PGD) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Illumina
Thermo Fisher
Agilent Technologies
PerkinElmer
Coopersurgical
Abbott Laboratories
Natera
Takara Bio
Oxford Gene Technology
Yikon Genomics
Progenesis
Beijing Genomics Institute
Invitae
Invicta Genetics
Combimatrix
Genea Limited
Bioarray
Quest Diagnostics
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
